Immunogen Inc (IMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
Sales | 108,782 | 69,856 | 132,299 | 82,271 | 53,446 |
Cost of Goods | 176 | N/A | N/A | N/A | N/A |
Gross Profit | 108,606 | 69,856 | 132,299 | 82,271 | 53,446 |
Operating Expenses | 329,675 | 194,929 | 154,679 | 174,444 | 214,895 |
Operating Income | -220,893 | -125,073 | -22,380 | -92,173 | -161,449 |
Interest Expense | 4,165 | 13,150 | 23,202 | 16,974 | 10,726 |
Other Income | 3,347 | -1,080 | 1,210 | 5,014 | 3,332 |
Pre-tax Income | -221,711 | -139,303 | -44,372 | -104,133 | -168,843 |
Income Tax | 1,218 | N/A | N/A | N/A | N/A |
Net Income Continuous | -222,929 | -139,303 | -44,372 | -104,133 | -168,843 |
Net Income | $-222,929 | $-139,303 | $-44,372 | $-104,133 | $-168,843 |
EPS Basic Total Ops | -0.88 | -0.68 | -0.25 | -0.70 | -1.21 |
EPS Basic Continuous Ops | -0.88 | -0.68 | -0.25 | -0.70 | -1.21 |
EPS Diluted Total Ops | -0.88 | -0.68 | -0.25 | -0.70 | -1.21 |
EPS Diluted Continuous Ops | -0.88 | -0.68 | -0.25 | -0.70 | -1.21 |
EPS Diluted Before Non-Recurring Items | -0.88 | -0.68 | -0.25 | -0.70 | -1.18 |
EBITDA(a) | $-219,110 | $-123,056 | $-20,279 | $-88,145 | $-154,038 |